Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.29) per share. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.
Barron’s Top Weekend Stock Picks: CVS, Chewy, Apple And Confusion On Tesla’s China Plant Is Hurting Stock
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.